Mild repetitive TBI reduces brain-derived neurotrophic factor (BDNF) in the substantia nigra and hippocampus: A preclinical model for testing BDNF-targeted therapeutics

This study provides an opportunity to investigate the mechanism of BDNF reduction in rodent models and provides a reliable paradigm to test BDNF-targeted therapeutics for the treatment of ND.PMID:38244886 | DOI:10.1016/j.expneurol.2024.114696

Source: Experimental Neurology - January 20, 2024 Category: Neurology Authors: Anisha A DSouza Praveen Kulkarni Craig F Ferris Mansoor M Amiji Benjamin S Bleier Source Type: research